ANVISA guidelines for two-stage design [Two-Stage / GS Designs]

posted by Mauricio Sampaio  – Brazil, 2020-02-12 17:11 (435 d 19:15 ago) – Posting: # 21167
Views: 3,851

Hi El Maestro
» Ermmm...... WHAT???? :-D:party:

Sorry! Change to: unknowledgement of intra-individual variability.

Now, any comments or contribution?

Complete thread:

Activity
 Admin contact
21,429 posts in 4,479 threads, 1,512 registered users;
online 13 (0 registered, 13 guests [including 2 identified bots]).
Forum time: Friday 13:26 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5